Demand for prostate specific antigen testing in primary care. Screening through back passage as well as back door?
作者信息
Hopcroft Keith
出版信息
BMJ. 2002 Mar 2;324(7336):547.
Abstract
摘要
相似文献
1
Demand for prostate specific antigen testing in primary care. Screening through back passage as well as back door?
BMJ. 2002 Mar 2;324(7336):547.
2
Prostate cancer screening--is the controversy resolved?
West J Med. 1995 Jul;163(1):65-6.
3
[Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
Lakartidningen. 2007;104(46):3460-4.
4
[Prostatic cancer screening].
Ugeskr Laeger. 2002 Jan 7;164(2):155-7.
5
Demand for prostate specific antigen testing in primary care. Can the demand for PSA testing in primary care be managed?
BMJ. 2002 Mar 2;324(7336):547.
6
New tests for prostate cancer may be nearing the clinic.
J Natl Cancer Inst. 2010 Jun 2;102(11):752-4. doi: 10.1093/jnci/djq210. Epub 2010 May 24.
7
[Differential diagnostic value of prostate-specific antigen in prostatic hyperplasia].
Urologiia. 2001 Mar-Apr(2):37-40.
8
Prostate cancer screening.
BJU Int. 2004 Nov;94(7):964-6. doi: 10.1111/j.1464-410X.2004.05187.x.
9
Application of prostate-specific antigen in prostate cancer.
MLO Med Lab Obs. 2008 Oct;40(10):54, 56-7.
10
Prostate specific antigen and screening for early prostate cancer.
N Z Med J. 2001 Apr 13;114(1129):150.
本文引用的文献
1
Screening for prostate cancer in the UK. Seems to be creeping in by the back door.
BMJ. 2001 Oct 6;323(7316):763-4. doi: 10.1136/bmj.323.7316.763.
2
Primary care perspective of prostate cancer screening after national guidance: a questionnaire survey.
J Med Screen. 2000;7(2):116-7. doi: 10.1136/jms.7.2.116.
Zotero 插件